Eating Disorders Clinical and Research Program, Massachusetts General Hospital, 2 Longfellow Place, Suite 200, Boston, MA, 02114, USA.
Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
Curr Psychiatry Rep. 2023 Feb;25(2):53-64. doi: 10.1007/s11920-022-01404-6. Epub 2023 Jan 14.
To review the literature pertaining to the assessment and treatment of avoidant/restrictive food intake disorder (ARFID) ten years following its introduction to DSM-5.
Several structured clinical interviews for assessing ARFID have been developed, each with its own strengths and limitations. There is no clear leading self-report measure for tracking treatment progress and outcome in ARFID. Medical assessment is comprised of examining anthropometrics, vitamin deficiencies, and other comorbidities. To date, several studies have reported on cognitive behavioral therapy, family-based treatment, and other approaches to the treatment of ARFID. These treatments appear promising; however, they rely on data from clinical case series and very small randomized controlled trials. Several promising assessments and treatments for ARFID are in the early stages of research. Yet, controversies remain. These include (a) overlap with criteria for pediatric feeding disorder; (b) the optimal method for assessing nutrient deficiencies; (c) disciplines involved in treatment. Future research innovation is necessary to improve the psychometric properties of ARFID assessments and evaluate treatment efficacy with larger samples and randomized designs.
目的综述：对 DSM-5 发布后十年内有关回避/限制型食物摄入障碍（ARFID）的评估和治疗的文献进行回顾。
最新发现：已经开发出几种用于评估 ARFID 的结构化临床访谈，每种方法都有其自身的优势和局限性。目前尚无明确的用于跟踪 ARFID 治疗进展和结果的主要自我报告量表。医学评估包括检查人体测量学、维生素缺乏和其他合并症。迄今为止，已有多项研究报告了认知行为疗法、家庭为基础的治疗以及其他针对 ARFID 的治疗方法。这些治疗方法似乎很有前景；然而，它们依赖于来自临床病例系列和非常小的随机对照试验的数据。几种针对 ARFID 的有前途的评估和治疗方法处于研究的早期阶段。然而，争议依然存在。这些争议包括：（a）与儿科喂养障碍标准的重叠；（b）评估营养缺乏的最佳方法；（c）治疗涉及的学科。需要进行未来的研究创新，以改善 ARFID 评估的心理计量学特性，并使用更大的样本和随机设计评估治疗效果。
